Bachem
  • Products & Services
    • CMC Development
      • Peptide NCES
      • Oligonucleotide NCEs
    • Commercial APIs
      • Commercial NCEs
      • Commercial Generics
    • Research & Specialties
      • Catalog Peptides
      • Custom Peptide Synthesis
      • Amino Acid Derivatives
      • Diagnostics
      • Cosmetic Peptides
    • Services & Capabilities
      • Project Management
      • Quality & Regulatory
      • Analytical capabilities
      • GMP Production
      • Research Grade Production
      • Supply & vertical integration
  • About Bachem
    • Company overview
      • Our Purpose
      • Our vision & strategy
      • Our Leadership
      • Our History
      • Our Locations
    • Innovation
      • Innovation matters
      • Innovation collaborations
    • Sustainability
      • People & culture
      • Safeguarding the environment
      • Acting ethically
    • Investors & Media
      • Reports & Presentations
      • Financial events
      • Media Library
      • Press archive
  • News & Events
    • News
    • Events
  • Careers
  • Contact
Select Page

MYMETICS-LED CONSORTIUM AWARDED €8.4 MILLION FOR DEVELOPMENT OF THERMO STABLE AND COLD-CHAIN INDEPENDENT VACCINES

April 23, 2015

Of the total amount, €3.4 million is directly attributable to Mymetics activities, with the balance going to the consortium partners, Catalent UK Swindon Zydis Ltd, Chimera Biotec GmbH (Germany), Upperton Ltd. (UK) and Bachem AG (Switzerland). 

 

more

← Bachem engages Professor Stephen B.H. Kent as Scientific Advisor and enters collaboration with the University of Chicago Peptide Trends June 2015 →

Meet Bachem: Johannes Kremser, Group Leader R&D

GalNAc conjugates: Delivery service to the liver!

Bachem announces the launch of their new website

Change in the Board of Directors of Bachem Holding AG

Bachem reports excellent results in 2020 – Sales exceed 400 million CHF for the first time

Peptide Trends February 2021

A New Turn in Peptide Purification

Innovation management

Peptide Trends January 2021

Bachem receives the Top Innovator Award from Alpora

Bachem Expanding into Oligonucleotides

Peptide Trends November 2020

Microspheres and Nanoparticles for Peptide Delivery

Changes to the Bachem Corporate Executive Committee

Peptide Trends October 2020

Peptide Trends September 2020

Oligonucleotide Trends September 2020

First half of 2020: Record sales and faster growth

Peptide Trends July 2020

Peptide Trends June 2020

Knowledge Center
General Conditions
Legal Statement
Privacy Policy
Imprint
Contact
  •  

  •  

  •  

  •  

  •